Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
pretreated for 30 min) attenuates the GPR55 agonists induced increases in hNSCs proliferation rates
QS11 inhibits migration of ARFGAP overexpressing breast cancer cells
InChi: InChI=1S/C18H20O6/c1-21-13-8-7-12(16(19)17(13)20)6-5-11-9-14(22-2)18(24-4)15(10-11)23-3/h5-10
6% in NCI-H460 (p<0
SR-4835 Size:Contact [email protected] for quotation pretreated for 30 min) attenuatesSR 4835 is a potent, highly selective and ATP competitive dual inhibitor of CDK12 CDK13 (CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4. 9 nM). SR 4835 acts in synergy with DNA damaging chemotherapy and PARP inhibitors and provokes triple negative breast cancer (TNBC) cell death. Product information CAS Number: 2387704 62 1 Molecular Weight: 499. 36 Formula: C21H20Cl2N10O Chemical Name: N [(5,6 dichloro 1H 1,3 benzodiazol 2 yl)methyl] 9 (1 methyl 1H pyrazol